It is well understood that the extent of red blood cell (RBC) aggregation is determined by both plasmatic and cellular factors [10] . It is also clear that alterations of plasmatic and cellular factors may be related to separate disease processes [1] . For example, plasma composition may change (e.g., fibrinogen concentration increase) due to an acute phase response, thereby altering RBC aggregation. Alternatively, RBC aggregation may be altered regardless of plasma composition due to modified cellular properties in certain pathophysiological processes (e.g., diabetes, ischemia/reperfusion injury) [5, 9] . Alterations of RBC properties that modify their intrinsic propensity to aggregate can be evaluated by measuring aggregation in standardized suspending media (e.g., isotonic 3% dextran 70 or 0.5% dextran 500 solutions). The use of standard media thus eliminates any plasmatic effects and solely reflects cell properties. These measurements in standardized suspending media can then be used to compare different RBC populations: greater aggregation indicates an enhanced tendency of the cells to form aggregates, while lesser aggregation indicates a decreased tendency. It has been suggested that the results of such comparisons reflect RBC "aggregability" [3] and hence intrinsic cellular characteristics such as surface properties (e.g., charge density, glycocalyx structure), membrane mechanical properties and cell shape.
